Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Imatinib

EU orphan designation number: EU/3/14/1357   
Active ingredient: Imatinib
Indication: Treatment of acute respiratory distress syndrome
Sponsor: Exvastat Limited
5 Tenison Avenue, Cambridge CB1 2DX, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2014 Orphan designation EMA/OD/110/14 (2014)8850 of 19/11/2014
14/03/2017 Transfer of orphan designation EMA/OD/110/14/T/01 (2017)1734 of 10/03/2017